Jeff Baxter - 27 Jul 2023 Form 4 Insider Report for VBI Vaccines Inc/BC

Reporting relationship: CEO, President, Director
Issuer ticker: N/A
Reported as of: 27 Jul 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 28 Jul 2023, 18:30:51 UTC
Prior SEC filing: 30 Jan 2023
Source filing: View source filing
Reporting owner signature: /s/ Jeff Baxter

Key filing fact

Jeff Baxter filed Form 4 for VBI Vaccines Inc/BC on 28 Jul 2023.

Key facts

This page summarizes Jeff Baxter's Form 4 filing for VBI Vaccines Inc/BC.
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 28 Jul 2023, 18:30.

Change

Previous filing in this sequence was filed on 30 Jan 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VBIV transaction Derivative

Option (Right to Buy Common Shares)

Award

Transaction value: $0
Shares: +70,000
Change %
Price: $0.000000
Shares after: 70,000
Date: 27 Jul 2023
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 70,000
Exercise price: $1.30
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The reporting person is a participant in the Issuer's Incentive Plan (the "Plan"). The board of directors of the Issuer approved the option grant on July 27, 2023 (the "Grant Date"). The options were granted pursuant to that certain option agreement entered into by and between the Issuer and the reporting person, dated July 27, 2023 (the "Option Agreement"). 25% of the options vest and become exercisable on the one-year anniversary of the Grant Date, with the remaining 75% of the options vesting and becoming exercisable in 24 equal monthly installments beginning on the first day of the month following the one-year anniversary of the Grant Date, subject to the reporting person's employment on the relevant vesting date.

Footnote F2

The options expire 10 years from the Grant Date unless terminated sooner in accordance with the Plan or the Option Agreement.